secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emmaus Life Sciences, Inc. (EMMA)
CIK:        0000822370
Form:       8-K
Filed at:   2024-05-28T23:59:59+00:00
Accession:  0001213900-24-047151
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emmaus Life Sciences amends bylaws to establish exclusive forum for stockholder litigation
--------------------------------------------------------------------------------

- Board adopted Amendment to Amended and Restated By-Laws on May 23, 2024.
- Delaware Chancery Court designated as sole forum for derivative and internal affairs actions.
- Federal district courts designated as exclusive forum for Securities Act claims.
- Amendment effective immediately; shareholders deemed to have consented.
- Exclusive forum provisions apply to actions based on duties, DGCL, and internal affairs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/822370/000121390024047151/0001213900-24-047151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/822370/000121390024047151/ea0206971-8k_emmaus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-047151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer